Jan 3 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O:
CYCLACEL PHARMACEUTICALS ANNOUNCES AGREEMENT FOR THE ACQUISITION OF PREFERRED STOCK BY DAVID LAZAR
CYCLACEL PHARMACEUTICALS INC - SPIRO ROMBOTIS STEPS DOWN AS CEO, DAVID LAZAR APPOINTED INTERIM CEO
CYCLACEL PHARMACEUTICALS INC - BOARD DIRECTS MANAGEMENT TO REDUCE OPERATING COSTS
Source text: ID:nGNX5yWZVZ
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
No relevant data is available
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."